A resolution designating July 15, 2026, as "Glioblastoma Awareness Day".

Designates July 15, 2026 as Glioblastoma Awareness Day to boost public attention and research. The resolution highlights that glioblastoma will affect more than 13,000 people in 2026, has a 7 percent five-year survival rate and a median survival of 8 months, and that only five drugs and one medical device have FDA approval for the disease. It honors patients and caregivers, stresses the importance of molecular biomarker testing, urges collaboration across government, private, and nonprofit groups, and encourages continued investment including through the Glioblastoma Therapeutics Network.